Half of the patients required a warfarin dose reduction and/or withheld dose, which further confirms the clinical relevance of this interaction. This INR increase was observed, on average ...
Specifically, we sought to determine (1) whether the within-patient mean warfarin dosage required to maintain INR values within the goal range of 2.0–3.0 was significantly different before and ...
warfarin dose and vitamin K intake) and genetic factors (CYP2C9 and VKORC1 genotype). In addition, patients with severe CKD had much poorer anticoagulation control (that is, spent less time in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback